2023年8月8日，歐盟食品安全局（EFSA）發布消息稱，擬修訂肟菌酯（trifloxystrobin）在蜂蜜中的最大殘留限量。
根據歐盟條例（EC）No 396/2005第6章的規定，Bayer AG Crop Science Division提交了該修訂申請。經過評估，歐盟食品安全局得出結論，短期和長期攝入因使用肟菌酯而產生的殘留物不太可能對消費者健康構成風險。消費者風險評估應被視為指示性的，并受不確定性的影響。部分原文報道如下：
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer AG Crop Science Division submitted a request to the competent national authority in the Netherlands to set a maximum residue level (MRL) for the active substance trifloxystrobin in honey. The data submitted in support of the request were found to be sufficient to derive an MRL proposal for the commodity under assessment. An adequate analytical method for enforcement is available to control the residues of trifloxystrobin in honey at the validated limit of quantification (LOQ) of 0.01 mg/kg. based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the potential transfer of residues into honey assessed in the present MRL application of trifloxystrobin is unlikely to present a risk to consumer health. The consumer risk assessment shall be regarded as indicative and affected by uncertainties.
根據歐盟條例（EC）No 396/2005第6章的規定，Bayer AG Crop Science Division提交了該修訂申請。經過評估，歐盟食品安全局得出結論，短期和長期攝入因使用肟菌酯而產生的殘留物不太可能對消費者健康構成風險。消費者風險評估應被視為指示性的，并受不確定性的影響。部分原文報道如下：
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer AG Crop Science Division submitted a request to the competent national authority in the Netherlands to set a maximum residue level (MRL) for the active substance trifloxystrobin in honey. The data submitted in support of the request were found to be sufficient to derive an MRL proposal for the commodity under assessment. An adequate analytical method for enforcement is available to control the residues of trifloxystrobin in honey at the validated limit of quantification (LOQ) of 0.01 mg/kg. based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the potential transfer of residues into honey assessed in the present MRL application of trifloxystrobin is unlikely to present a risk to consumer health. The consumer risk assessment shall be regarded as indicative and affected by uncertainties.
